The company will use the money to try to establish its cuffless device as a go-to option for 24-hour blood pressure ...
To derive blood pressure, the device measures the time-of-flight between ultrasound echoes reflected from the anterior and ...
Biobeat closed a $50M Series B, led by Ally Bridge, OrbiMed, and Elevage, to expand U.S. commercialization of its 24 hour FDA ...
(HealthDay News) — Patients suspected of having hypertension may soon be asked to wear an ambulatory blood pressure monitor to confirm the diagnosis, according to a draft recommendation issued by the ...
*The main analyses of ambulatory BP endpoints include patients with valid ambulatory blood pressure monitoring at both baseline and Week 12, without imputation of missing data. The Phase III Bax24 ...
Accurate, continuous blood pressure (BP) monitoring is essential for preventing cardiovascular events, yet conventional cuffs ...
A new system that uses dehydrated alcohol to deactivate certain nerves surrounding the kidneys' arteries in order to control high blood pressure met its primary endpoint—lowering blood pressure at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback